Medline Inc. (MDLN)
NASDAQ: MDLN · Real-Time Price · USD
33.07
-0.84 (-2.48%)
Aug 20, 2026, 12:37 PM EDT - Market open
Medline Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| 29,939 | 28,432 | 25,507 | 23,231 | 21,448 | |
Revenue Growth | 12.12% | 11.47% | 9.80% | 8.31% | - |
Cost of Revenue | 22,094 | 20,914 | 18,531 | 17,346 | 16,231 |
Gross Profit | 7,845 | 7,518 | 6,976 | 5,885 | 5,217 |
Selling, General & Admin | 4,904 | 4,567 | 4,108 | 3,867 | 3,676 |
Amortization of Goodwill & Intangibles | 706 | 704 | 685 | 662 | 660 |
Other Operating Expenses | 409 | 68 | 35 | -55 | 20 |
Operating Expenses | 6,019 | 5,339 | 4,828 | 4,474 | 4,356 |
Operating Income | 1,826 | 2,179 | 2,148 | 1,411 | 861 |
Interest Expense | -781 | -945 | -1,144 | -1,213 | -899 |
Interest & Investment Income | 147 | 133 | 280 | 237 | 27 |
Currency Exchange Gain (Loss) | - | -88 | 7 | -11 | 11 |
Other Non Operating Income (Expenses) | -47 | -6 | -11 | 1 | 10 |
EBT Excluding Unusual Items | 1,145 | 1,273 | 1,280 | 425 | 10 |
Legal Settlements | -10 | 33 | -2 | -161 | - |
Other Unusual Items | -58 | -58 | -32 | - | - |
Pretax Income | 1,077 | 1,248 | 1,246 | 264 | 10 |
Income Tax Expense | 197 | 91 | 46 | 30 | 35 |
Earnings From Continuing Operations | 880 | 1,157 | 1,200 | 234 | -25 |
Minority Interest in Earnings | -187 | 2 | - | - | - |
Net Income | 693 | 1,159 | 1,200 | 234 | -25 |
Net Income to Common | 701 | 1,159 | 1,200 | 234 | -25 |
Net Income Growth | -44.72% | -3.42% | 412.82% | - | - |
Shares Outstanding (Basic) | 877 | 810 | 17,467 | 17,500 | - |
Shares Outstanding (Diluted) | 877 | 810 | 17,467 | 17,500 | - |
Shares Change | -94.99% | -95.36% | -0.19% | - | - |
EPS (Basic) | 0.80 | 1.43 | 0.07 | 0.01 | - |
EPS (Diluted) | 0.80 | 1.43 | 0.07 | 0.01 | - |
EPS Growth | 998.36% | 1982.77% | 413.80% | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | 1,546 | 1,264 | 1,405 | 1,400 | -67 |
Free Cash Flow Per Share | 1.76 | 1.56 | 0.08 | 0.08 | - |
Gross Margin | 26.20% | 26.44% | 27.35% | 25.33% | 24.32% |
Operating Margin | 6.10% | 7.66% | 8.42% | 6.07% | 4.01% |
Profit Margin | 2.34% | 4.08% | 4.71% | 1.01% | -0.12% |
Free Cash Flow Margin | 5.16% | 4.45% | 5.51% | 6.03% | -0.31% |
EBITDA | 2,850 | 3,190 | 3,125 | 2,362 | 1,794 |
EBITDA Margin | 9.52% | 11.22% | 12.25% | 10.17% | 8.36% |
D&A For EBITDA | 1,024 | 1,011 | 977 | 951 | 933 |
EBIT | 1,826 | 2,179 | 2,148 | 1,411 | 861 |
EBIT Margin | 6.10% | 7.66% | 8.42% | 6.07% | 4.01% |
Effective Tax Rate | 18.29% | 7.29% | 3.69% | 11.36% | 350.00% |